The Development of Cytokine Receptor Antagonists as Potential Therapeutic Agents for the Myeloproliferative Disorders

E-ISSN： 1873-4286|8|5|357-368

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.5, 2002-03, pp. : 357-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of endothelin receptor antagonists as potential therapeutic agents

By Ergul Adviye

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 33-44

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E. Noll G. Lüscher T.F.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A. Popik P. Bespalov A.Y. Danysz W.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite

Substance P Receptor Antagonists in Psychiatry: Rationale for Development and Therapeutic Potential

By Herpfer Inga Lieb Klaus

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 275-293

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Vasopressin Receptor Antagonists

By Ali Farhan Guglin Maya Vaitkevicius Peter Ghali Jalal K.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 847-858

Adis International

Access to resources Recommend Favorite